Pulse News Wire translates Japanese corporate disclosures filed with the Tokyo Stock Exchange's TDNet system into clear, structured English for institutional investors, hedge funds, and asset managers. Every article on this page is derived directly from an official TDNet filing — including earnings reports, M&A announcements, share buybacks, dividend declarations, and governance changes. Japanese corporate governance is governed by the Companies Act and the Financial Instruments and Exchange Act; timely translation of these disclosures provides a material information advantage for cross-border investors monitoring Tokyo-listed equities.
This corporate disclosure from DOUTOR・NICHIRES Holdings Co.,Ltd. was processed by Pulse News Wire on April 14, 2026. It represents a primary source document for Japanese M&A sector intelligence, translated directly from an official filing submitted to the Tokyo Stock Exchange TDNet system.
TOKYO, Apr 14 (Pulse News Wire) — DOUTOR・NICHIRES Holdings Co.,Ltd. (TYO: 3087) announced a business transfer at its subsidiary.
View all DOUTOR・NICHIRES Holdings Co.,Ltd. disclosures →
DOUTOR・NICHIRES Holdings Co.,Ltd. [3087.T]
TOKYO, Apr 14 (Pulse News Wire) — DOUTOR・NICHIRES Holdings Co.,Ltd. (TYO: 3087) announced a business transfer at its subsidiary.
🟡 Confidence: Standard AI-translated content.